
The suspension of Trasylol, a drug used in heart surgeries sales that has been proven to be fatal, has caused for much talk. Trasylol lawsuits from the families of those affected by the drug’s side-effects will be filed soon, and a Trasylol class-action lawsuit can not be far off. With fatalities over 22,000, Bayer is going to be struggling to find a way out. The drug was speculated to have problems back in 2006, yet it was still approved by the FDA. The reason for this is that Bayer failed to present their research about the relation of kidney failure & Trasylol to the FDA in their September 2006 meeting. The chairman of that FDA advisory panel, Dr. William Hiatt, said that he would have voted for a Trasylol recall back in 2006 if Bayer had not withheld the data from their study
The high cost of Trasylol has also posed questions due to the fact that it was a lot more expensive at $1,250, than of competitors at $150. This makes us wonder if Bayer was not only producing a defection medication, but also gouging prices from those who were administered Trasylol. What we do know is that Bayer is going to need more than a drug to cure there worries
Napoli Bern Ripka LLP is an experienced firm in the medical negligence field and can provide you with the right information on how to proceed with your case. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. We are here to help you questions that you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation.
Read More about "Trouble for Bayer as Lawsuits Draw Near"
Bayer Pharmaceutical, the large drug manufacturer, has announced that it has taken its remaining stock of Trasylol out of hospitals. This anti-bleeding medication has been linked to causing kidney damage and death in over 22,000 cases. The reason that Bayer recalled the drug was in response from studies that show Trasylol nearly doubled the death rate in comparison to cheaper alternative medications that were already established in the market. These studies that proved Trasylol, also called aprotinin, is more dangerous when used in heart surgeries were given to Bayer nearly two years before it was taken off the market. Bayer even did their own study, in which the finding also discovered the fatal side effects of the drug.
Now that Trasylol has been taken off the market it is time to recoup all that has been lost. This is another example of large drug company whose questionable motives have cost numerous lives and much grief. The firm of Napoli Bern Ripka, LLP represents victims of such second-rate care and negligence. We have the experienced legal team that has successfully represented thousands of clients injured by medical drugs such as Fen-phen, Baycol, and Rezulin, and are here to help you with any Trasylol questions you may have.
Read More about "Bayer Recalls Popular Drug Used In Heart Surgery"
Napoli Bern LLP
350 5th Avenue
Suite 7413
New York, NY 10118
Toll Free: 877 WTC HERO
Phone: 212 267 3700
Napoli Bern LLP
350 5th Avenue, Suite 7413,
New York, NY 10118
Toll Free: 1 888 LAW IN NY
Phone: 212 267 3700
New Jersey
1 Greentree Centre
Suite 201
Marlton, NJ 08053
New York
350 5th Avenue,
Suite 7413,
New York, NY 10118
3500 Sunrise Highway,
Suite T-207
Great River, NY 11739
Pennsylvania
2 Penn Center, Suite 200
Philadelphia, PA 19102
New York Defective Drugs and Medical Devices Lawyers
New York Auto Accident Lawyers
New York Construction and Jobsite Accident Lawyers
Marc Bern discusses the Diet Drug FenPhen on Geraldo
Marc Bern on CourtTV discussing Fen-Phen
Marc Bern is on Geraldo discussing the diet drug Fen-Phen
Trial Attorney Marc Bern discusses Breast Implants on Court TV
Marc Bern on CourtTV discussing breast implant litigation
Nancy Grace with Marc Bern about Jenny Jones Trial
New York Trial Attorney Marc Bern on Court TV